Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing
globally in recent years, particularly as a result of randomised studies in which it has been …

Background Clostridium difficile infection causes severe complications and frequently recurs.
An extended-pulsed fidaxomicin regimen might facilitate sustained clinical cure by …

Background Faecal microbiota transplantation (FMT) is an emerging treatment modality, but
its current clinical use and organisation are unknown. We aimed to describe the clinical use, …

Objectives Recent advances in the laboratory detection of infectious diarrhoea allow more
rapid and sensitive identification of infected patients. Several commercial multiplex molecular …

From its origins as a left-field, experimental, and even “maverick” intervention, faecal
microbiota transplantation (FMT) is now a well-recognised, accepted, and potentially life-saving …

Background Faecal microbiota transplantation is an emerging therapeutic option, particularly
for the treatment of recurrent Clostridioides difficile infection. Stool banks that organise …

Background Identifying and tackling the social determinants of infectious diseases has
become a public health priority following the recognition that individuals with lower …

The role of heater–cooler units (HCUs) in the transmission of Mycobacterium chimaera
during open heart surgery has been recognized since 2013. Subsequent investigations …

Objectives To estimate the costs and benefits of clinical pathways incorporating a point of
care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in …

The production of binary toxin and presence of truncating mutations in the putative toxin
repressor gene, tcdC, have been associated with the increased virulence and spread of …